BioMarin

$76.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-0.12%) As of 7:25 PM UTC today

Why Robinhood?

You can buy or sell BioMarin and other stocks, options, and ETFs commission-free!

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO
Jean-Jacques Bienaimé
Employees
3,059
Headquarters
San Rafael, California
Founded
1997
Market Cap
14.03B
Price-Earnings Ratio
17.03
Dividend Yield
—
Average Volume
1.09M
High Today
$77.45
Low Today
$76.38
Open Price
$76.71
Volume
592.22K
52 Week High
$131.95
52 Week Low
$71.35

BMRN Earnings

-$0.19
$1.21
$2.61
$4.01
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 28, After Hours

You May Also Like

HIGA=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure